Cart summary

You have no items in your shopping cart.

Fingolimod hydrochloride

SKU: orb1305341

Description

Fingolimod hydrochloride

Research Area

Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

CAS Number162359-56-0
MW343.93
Purity99.69%
FormulaC19H34ClNO2
SMILESCl.CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1
TargetPAK,TRP/TRPV Channel,S1P Receptor,LPL Receptor
SolubilityDMSO:102 mg/mL (296.57 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.82 mM);H2O:34.4 mg/mL (100.02 mM)

Bioactivity

Target IC50
S1P:0.033 nM (K562 and NK cells)
In Vivo
Administration of the immunomodulator FTY720 increased serum S1P, improved impaired systolic contractility and activated the PI3K-pathway in the heart. Cardioprotective effects of FTY720 were abolished following administration of an S1P receptor 2 (S1P2) antagonist or a PI3K inhibitor. Sphingosine kinase-2 deficient mice had higher endogenous S1P levels and the LPS/PepG-induced impaired systolic contractility was attenuated in comparison with wild-type mice . Using human ALL xenografts in NOD/SCIDγc(-/-) mice, three Ph(+) human ALL xenografts responded to FTY720 with an 80 ± 12% reduction in overall disease when treatment was commenced early. In contrast, treatment of mice with FTY720 did not result in reduced leukemia compared to controls using four separate human Ph(-) ALL xenografts .
In Vitro
The cultures of K562 and NK cells were incubated in the presence of 2 μM S1P and increasing concentrations of Fingolimod (FTY720). Addition of various concentrations of FTY720 blocked the inhibitory effect of S1P with an IC50 value calculated at 0.033 nM. The combination of S1P with FTY720 did not affect the expression of these molecules on the surface of iDCs. In addition, 10 nM FTY720 when incubated alone exerted no effect on the expression of co-stimulatory molecules . FTY720 was able to reduce excitotoxic neuronal death in vitro. FTY720 negatively modulates p38 MAPK in LPS-activated microglia, whereas it had no effect on JNK1/2 activation .
Cell Research
DCs or NK cells were incubated at a cell concentration of 1 × 10^6 cells/ml with either media or with 2 μM S1P, 10 nM SEW2871, 10 nM FTY720 or their combinations. DCs were also incubated with 1 μg/ml LPS. After 24 h incubation, the cells were harvested and the cell suspensions were centrifuged at 1,000 × g for 10 min before the supernatants were collected. Detection of the levels of various cytokines and chemokines was carried utilizing the Multi-Analyte ELISArray Kit as described by the manufacturers' user manual .
Animal Research
This study was carried out on 2-month-old male C57BL/6J mice or sphingosine kinase-2 deficient (SPHK-2 / ) mice weighing 25–30 g, receiving a standard diet and water ad libitum. C57BL/6J wild-type or SPHK-2 / mice received i.p.-injections of LPS (9 mg/kg)/PepG (1 mg/kg) or its vehicle (0.9% saline). Sham mice were not subjected to LPS/PepG but were otherwise treated in the same way. At 1 h after LPS/PepG challenge, mice were treated with FTY720 (0.1 mg/kg i.v.) or its vehicle (10% DMSO). To elucidate the role of different S1P receptors in the observed effects of FTY720, mice received (45 min after LPS/PepG and 15 min prior to FTY720) the selective phosphatidylinositol 3 (PI3)-kinase inhibitor LY294002 (0.3 mg/kg i.v.) or the selective S1P2 receptor antagonist JTE 013 (1 mg/kg i.v.) or (1 h after LPS/PepG) the selective S1P1 receptor agonist SEW2871 (1 mg/kg i.v.) or vehicle (10% DMSO) .

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

LPLReceptor, LPL, LPL Receptor, PAK, Fingolimod, Fingolimod (FTY720) HCl, FTY 720, FTY720, FTY-720, FTY720 HCl, p21 activated kinases, S1P Receptor, S1P, S1PReceptor, TRP Channel, TRPVChannel, TRPV Channel, TRPChannel, Trpm7

Similar Products

  • Fingolimod hydrochloride [orb1226037]

    >98% (HPLC)

    162359-56-0

    343.9

    C19H34ClNO2

    1 g, 500 mg, 50 mg, 100 mg, 200 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Fingolimod hydrochloride (orb1305341)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

50 mg
¥ 1,040.00
1 ml x 10 mM (in DMSO)
¥ 1,170.00
100 mg
¥ 1,170.00
500 mg
¥ 2,210.00
1 g
¥ 2,730.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry